MarginsXMarginsX
Home › Markets › GTHP

Guided Therapeutics Inc (GTHP)

GTHP is quoted over the counter, not listed on an exchange. Guided Therapeutics Inc files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.

Close · November 13, 2026
$0.1100
-8.3% on the day
1-year return
-51.1%
Market cap
$10.6M
Nano cap. From the Nov 13, 2026 close × 96.5M shares (10-Q cover page, Aug 7, 2026)
P/E and P/S
Net loss over the period · 16.3×
On trailing twelve months to June 30, 2026 (10-Q)

Closes: Yahoo Finance daily closes, last bar 2026-11-13.

Profile

FieldValue
TickerGTHP, quoted over the counter
SEC CIK0000924515
OTC Markets tierOTCQB (price source, 2026-11-13)
SEC industry codeElectromedical & Electrotherapeutic Apparatus
Business addressPeachtree Corners, GA
Incorporated inDE

Warning signs

Cash runway
0.1 months
$12K cash at June 30, 2026
Share count, 1 year
+20.2%
2025-08-11 to 2026-08-07 · +88.2% over 3 years
Going-concern doubt
Yes
10-Q filed August 13, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"The factors below raise substantial doubt about the Company's ability to continue as a going concern."
10-Q 2026-08-13
Cash and burn$12K cash; operating cash flow -$376K a quarter.Report 2026-06-30
Shares outstanding96,537,349 (2026-08-07); 80,283,991 a year earlier; 51,288,937 three years earlier.Cover page 2026-08-07
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorUHY LLP, Sterling Heights, Michigan, United StatesPCAOB Form AP 2026-04-28
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
$0-$605K-$319K$12K$53K$650K10-Q 2026-08-13
Q1 2026
2026-03-31
$0-$500K-$617K$369K$91K$767K10-Q 2026-05-15
Q4 2025
2025-12-31
$590K-$1.2M-$291K$63K$534K$767K10-K 2026-03-31
Q3 2025
2025-09-30
$60K-$742K-$277K$87K$556K$178K10-Q 2025-11-13
Q2 2025
2025-06-30
$117K-$811K-$169K$185K$445K$118K10-Q 2026-08-13
Q1 2025
2025-03-31
$0-$427K-$331K$115K$35K$1K10-Q 2026-05-15
Q4 2024
2024-12-31
$1K-$652K-$332K$388K$270K$7K10-K 2026-03-31
Q3 2024
2024-09-30
$0-$654K-$473K$194KNo debt tags$38K10-Q 2025-11-13

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-12023-01-13
Latest annual report10-K2026-03-31
Latest quarterly / interim10-Q2026-11-16
Latest current report8-K2026-03-10
Latest proxyDEF 14A2021-07-06

Source: SEC EDGAR submissions feed, 1,001 recent filings. All filings on EDGAR.

The full dossier has every filing, quarterly and annual financials, the health record and a price chart.

Open the full dossier